UNICA IRIS Institutional Research Information System

DEPLANO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 77.090
NA - Nord America 3.298
AS - Asia 1.408
SA - Sud America 314
Continente sconosciuto - Info sul continente non disponibili 211
AF - Africa 65
OC - Oceania 24
Totale 82.410
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 76.309
US - Stati Uniti d'America 3.225
SG - Singapore 590
CN - Cina 392
BR - Brasile 245
SE - Svezia 178
VN - Vietnam 141
UA - Ucraina 137
DE - Germania 93
GB - Regno Unito 77
FR - Francia 75
FI - Finlandia 66
ES - Italia 49
IN - India 46
CA - Canada 45
HK - Hong Kong 45
BD - Bangladesh 28
AR - Argentina 27
AU - Australia 23
PK - Pakistan 22
IQ - Iraq 20
RU - Federazione Russa 18
MA - Marocco 16
PL - Polonia 16
JP - Giappone 15
BE - Belgio 14
EC - Ecuador 14
EG - Egitto 14
ZA - Sudafrica 14
KR - Corea 13
MX - Messico 13
VE - Venezuela 13
ID - Indonesia 12
NL - Olanda 10
TR - Turchia 10
TW - Taiwan 9
AT - Austria 8
AZ - Azerbaigian 7
CO - Colombia 7
DZ - Algeria 7
PT - Portogallo 7
IL - Israele 6
JM - Giamaica 6
PH - Filippine 6
UZ - Uzbekistan 6
HU - Ungheria 5
IR - Iran 5
JO - Giordania 5
RO - Romania 5
LT - Lituania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CR - Costa Rica 3
IE - Irlanda 3
KE - Kenya 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
CL - Cile 2
HR - Croazia 2
LB - Libano 2
MY - Malesia 2
PY - Paraguay 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 82.199
Salva come PNG Salva come JPEG
Città #
Cagliari 74.828
Uta 1.263
Ashburn 486
Singapore 328
Fairfield 204
Chandler 188
San Jose 182
Woodbridge 171
Dallas 142
Wilmington 120
Boardman 118
Nyköping 112
Houston 107
Ann Arbor 104
Seattle 95
Beijing 77
Cambridge 70
Council Bluffs 68
Jacksonville 64
Dearborn 63
Santa Clara 60
Los Angeles 59
Shanghai 48
São Paulo 37
Helsinki 36
New York 35
Ho Chi Minh City 32
Hanoi 31
Hong Kong 29
Nanjing 29
Boston 28
Dong Ket 28
Lauterbourg 28
San Diego 28
Chicago 25
Buffalo 22
Washington 22
Barcelona 21
Milan 20
The Dalles 20
Frankfurt am Main 17
Toronto 16
Canberra 15
Hefei 15
Munich 15
Redwood City 14
Guangzhou 13
Orem 13
Perugia 13
Sassari 13
Casablanca 12
Phoenix 12
Brooklyn 11
Jiaxing 11
Nanchang 11
Tokyo 11
Brussels 10
Hyderabad 10
Johannesburg 10
Tianjin 10
Turku 10
Atlanta 9
Paris 9
Seoul 9
Central 8
Changsha 8
Chapel Hill 8
Columbus 8
Denver 8
Hebei 8
Madrid 8
Messina 8
Mountain View 8
Olbia 8
Champaign 7
Dhaka 7
Ferrara 7
London 7
Ottawa 7
Tappahannock 7
Baku 6
Belo Horizonte 6
Brunswick 6
Cairo 6
Kingston 6
Maia 6
Nuremberg 6
Quartu Sant'elena 6
Quito 6
Saint Augustine 6
San Mateo 6
Shenyang 6
Springfield 6
Sydney 6
Warsaw 6
Amman 5
Amsterdam 5
Baghdad 5
Basingstoke 5
Biên Hòa 5
Totale 79.954
Salva come PNG Salva come JPEG
Nome #
In vitro nematicidal activity of aryl hydrazones and comparative GC-MS metabolomics analysis 12.079
Novel propanamides as fatty acid amide hydrolase inhibitors 5.100
Potent nematicidal activity of maleimide derivatives on Meloidogyne incognita 3.910
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.536
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.934
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.885
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.750
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.728
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.612
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.609
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.598
Interaction of the N-(3-Methylpyridin-2-yl)amide derivatives of flurbiprofen and ibuprofen with FAAH: Enantiomeric selectivity and binding mode 2.556
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.398
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor 2.363
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.261
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 2.250
Investigation of the mechanism of FAAH inhibition of profen amide derivatives 2.131
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors 1.822
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.801
null 1.768
null 1.650
Discovery of a novel class of profen derivatives as FAAH inhibitors: MD and QM/MM studies of the binding mode and 3D SAR 1.601
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors 1.558
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen 1.480
null 1.383
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.347
The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen 1.317
Design, synthesis and SAR of small molecules acting on pain pathways 1.301
Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents 1.131
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition 1.065
Homology modeling of a Class A GPCR in the inactive conformation: A quantitative analysis of the correlation between model/template sequence identity and model accuracy 959
Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen 873
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 844
Hydrophobic similarity between molecules: Application to three-dimensional molecular overlays with PharmScreen 837
Onthe use (QM) IEF/PMC-MST-derived hydrophobic contributions as physicochemical descriptors in 3D-QSAR: the PHARMSQSARTM approach 798
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 700
Design, synthesis and pharmacological investigation on new FAAH inhibitors 475
Totale 82.410
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.740
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.661 0 0 0 0 283 309 385 253 179 335 401 516
2022/20235.447 564 702 498 462 474 592 288 339 298 304 476 450
2023/20245.404 225 184 190 309 484 795 849 348 333 355 668 664
2024/202518.705 1.807 4.639 1.151 8.585 827 647 634 61 147 60 77 70
2025/20262.576 231 116 275 272 209 198 325 214 185 389 129 33
2026/2027582 56 78 203 245 0 0 0 0 0 0 0 0
Totale 82.410